FDA approves Rocket gene therapy for rare immune disorder

The Food and Drug Administration approved a gene therapy for severe leukocyte adhesion deficiency type 1 (LAD-1), an ultra-rare disease that leaves children vulnerable to life-threatening infections.

Read more here.

Previous post
Back to list